$GLTO
Galecto, Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024119809 Filed on November 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.747M
YoY Change -16.76%
% of Gross Profit
Research & Development $1.093M
YoY Change -57.15%
% of Gross Profit
Depreciation & Amortization $6.000K
YoY Change -97.16%
% of Gross Profit
Operating Expenses $3.840M
YoY Change -55.26%
Operating Profit -$3.840M
YoY Change -55.26%
Interest Expense -$36.00K
YoY Change -108.0%
% of Operating Profit
Other Income/Expense, Net -$36.00K
YoY Change -108.05%
Pretax Income -$3.876M
YoY Change -52.38%
Income Tax $7.000K
% Of Pretax Income
Net Earnings -$3.883M
YoY Change -52.27%
Net Earnings / Revenue
Basic Earnings Per Share -$3.39
Diluted Earnings Per Share -$3.39
COMMON SHARES
Basic Shares Outstanding 1.317M 27.13M
Diluted Shares Outstanding 1.145M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.68M
YoY Change -55.48%
Cash & Equivalents $19.68M
Short-Term Investments $0.00
Other Short-Term Assets $222.0K
YoY Change 11.0%
Inventory
Prepaid Expenses
Receivables $73.00K
Other Receivables $1.205M
Total Short-Term Assets $21.20M
YoY Change -54.99%
LONG-TERM ASSETS
Property, Plant & Equipment $62.00K
YoY Change -50.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.104M
YoY Change -12.95%
Total Long-Term Assets $2.176M
YoY Change -26.21%
TOTAL ASSETS
Total Short-Term Assets $21.20M
Total Long-Term Assets $2.176M
Total Assets $23.38M
YoY Change -53.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $503.0K
YoY Change -88.76%
Accrued Expenses $1.938M
YoY Change -76.01%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.400M
YoY Change -80.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.400M
Total Long-Term Liabilities $0.00
Total Liabilities $2.441M
YoY Change -80.73%
SHAREHOLDERS EQUITY
Retained Earnings -$270.8M
YoY Change 8.49%
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.94M
YoY Change
Total Liabilities & Shareholders Equity $23.38M
YoY Change -53.29%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$3.883M
YoY Change -52.27%
Depreciation, Depletion And Amortization $6.000K
YoY Change -97.16%
Cash From Operating Activities -$3.651M
YoY Change -56.84%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -3.651M
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000
Net Change In Cash -3.651M
YoY Change 36410.0%
FREE CASH FLOW
Cash From Operating Activities -$3.651M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001800315
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
CY2024Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.04
CY2023Q4 glto Debt Securities Available For Sales Type Extensible List
DebtSecuritiesAvailableForSalesTypeExtensibleList
us-gaap:CorporateDebtSecuritiesMember
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilities
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilities
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39655
dei Entity Registrant Name
EntityRegistrantName
GALECTO, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1957007
dei Entity Address Address Line1
EntityAddressAddressLine1
75 State Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02109
dei City Area Code
CityAreaCode
+45
dei Local Phone Number
LocalPhoneNumber
70 70 52 10
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
GLTO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1316989
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19678000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21465000
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
11686000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1500000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3623000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
21178000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
36774000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
247000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
62000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2104000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1128000
CY2024Q3 us-gaap Assets
Assets
23376000
CY2023Q4 us-gaap Assets
Assets
38227000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
503000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1702000
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1938000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4128000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2441000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5830000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
66000
CY2024Q3 us-gaap Liabilities
Liabilities
2441000
CY2023Q4 us-gaap Liabilities
Liabilities
5896000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1253843
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1253843
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1084508
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1084508
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
291053000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
288036000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-270783000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-256085000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
665000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
380000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
20935000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
32331000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23376000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38227000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1093000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2551000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5390000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21002000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2747000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3304000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8800000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9504000
CY2023Q3 us-gaap Restructuring Costs
RestructuringCosts
2728000
us-gaap Restructuring Costs
RestructuringCosts
968000
us-gaap Restructuring Costs
RestructuringCosts
2728000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
3840000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
8583000
us-gaap Operating Expenses
OperatingExpenses
15158000
us-gaap Operating Expenses
OperatingExpenses
33234000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3840000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8583000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15158000
us-gaap Operating Income Loss
OperatingIncomeLoss
-33234000
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
146000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
473000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
616000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1349000
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-182000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-26000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-107000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
11000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-36000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
447000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
509000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1360000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3876000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8136000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14649000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31874000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-3883000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8136000
us-gaap Net Income Loss
NetIncomeLoss
-14698000
us-gaap Net Income Loss
NetIncomeLoss
-31874000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.39
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.39
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.5
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.5
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-13.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-30.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-30.19
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1144978
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1144978
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1084191
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1084191
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1104849
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1104849
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1055679
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1055679
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
468000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
127000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
251000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
117000
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
56000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
34000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
173000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
468000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
183000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
285000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
290000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3415000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7953000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14413000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31584000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
23588000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
681000
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
81000
CY2024Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-25
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
468000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-3883000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
20935000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43700000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1464000
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
171000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
183000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8136000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
37382000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
32331000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2931000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
86000
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-25
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
285000
us-gaap Net Income Loss
NetIncomeLoss
-14698000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
20935000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
61753000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4337000
glto Stock Issued During Period Net Of Issuance Costs
StockIssuedDuringPeriodNetOfIssuanceCosts
200000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2876000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
290000
us-gaap Net Income Loss
NetIncomeLoss
-31874000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
37382000
us-gaap Profit Loss
ProfitLoss
-14698000
us-gaap Profit Loss
ProfitLoss
-31874000
us-gaap Depreciation
Depreciation
16000
us-gaap Depreciation
Depreciation
246000
us-gaap Share Based Compensation
ShareBasedCompensation
2931000
us-gaap Share Based Compensation
ShareBasedCompensation
4337000
glto Issuance Of Common Stock In Connection With Vesting Of Restricted Stock Units
IssuanceOfCommonStockInConnectionWithVestingOfRestrictedStockUnits
-86000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-70000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
406000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
219000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
355000
glto Accretion Of Lease Liability
AccretionOfLeaseLiability
9000
glto Accretion Of Lease Liability
AccretionOfLeaseLiability
40000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2121000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-812000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
974000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
141000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1199000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1127000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2040000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
445000
glto Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-228000
glto Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-378000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13687000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25437000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
25937000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11650000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
38687000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11650000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12750000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2876000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2876000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2037000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9811000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
250000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21465000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32786000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19678000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23078000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-270800000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13700000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25400000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-3900000
us-gaap Profit Loss
ProfitLoss
-14700000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-8100000
us-gaap Profit Loss
ProfitLoss
-31900000
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
19700000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
21200000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2400000
CY2023Q4 us-gaap Investments And Cash
InvestmentsAndCash
33200000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
36800000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5800000
CY2023Q3 glto Number Of Employees Reduced Due To Restructuring
NumberOfEmployeesReducedDueToRestructuring
29
CY2023Q3 glto Work Force Reduction Precentage
WorkForceReductionPrecentage
0.70
CY2024Q2 glto Number Of Employees Reduced Due To Restructuring
NumberOfEmployeesReducedDueToRestructuring
8
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
4400000
CY2024Q3 us-gaap Restructuring Costs
RestructuringCosts
0
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
107000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
107000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
45000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
62000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78000
CY2024Q3 us-gaap Depreciation
Depreciation
6000
us-gaap Depreciation
Depreciation
16000
CY2023Q3 us-gaap Depreciation
Depreciation
211000
us-gaap Depreciation
Depreciation
246000
CY2024Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
8856000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
25296000
CY2024Q3 glto Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
949000
CY2023Q4 glto Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
1438000
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
89000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
774000
CY2024Q3 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
256000
CY2023Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
280000
CY2024Q3 glto Contract Research And Development Cost Current
ContractResearchAndDevelopmentCostCurrent
73000
CY2023Q4 glto Contract Research And Development Cost Current
ContractResearchAndDevelopmentCostCurrent
1046000
CY2024Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
133000
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
85000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1500000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3623000
CY2024Q3 glto Operating Lease Rent Expense
OperatingLeaseRentExpense
50000.00
glto Operating Lease Rent Expense
OperatingLeaseRentExpense
200000
CY2023Q3 glto Operating Lease Rent Expense
OperatingLeaseRentExpense
200000
glto Operating Lease Rent Expense
OperatingLeaseRentExpense
500000
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
49000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
135000
us-gaap Operating Lease Cost
OperatingLeaseCost
192000
us-gaap Operating Lease Cost
OperatingLeaseCost
411000
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
50000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
121000
us-gaap Operating Lease Payments
OperatingLeasePayments
190000
us-gaap Operating Lease Payments
OperatingLeasePayments
394000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y2M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y10M24D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
33000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
33000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
32000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
809000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
987000
CY2024Q3 glto Contract Research And Development Costs Current
ContractResearchAndDevelopmentCostsCurrent
247000
CY2023Q4 glto Contract Research And Development Costs Current
ContractResearchAndDevelopmentCostsCurrent
685000
CY2024Q3 us-gaap Restructuring Reserve
RestructuringReserve
230000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
1734000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
32000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
183000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
620000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
539000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1938000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4128000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
275478
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
114.4
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4320
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.25
glto Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
130
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
97593
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
103.56
glto Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledIntrinsicValue
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
182205
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
117.78
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M18D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
172493
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
116.87
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y3M18D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
160204
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
126.1
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
681000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1464000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2931000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4337000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.042
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.038
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.993
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.910
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q2 glto Number Of Employees Reduced Due To Restructuring
NumberOfEmployeesReducedDueToRestructuring
8
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
0
CY2023 us-gaap Restructuring Charges
RestructuringCharges
3448000
CY2023 us-gaap Payments For Restructuring
PaymentsForRestructuring
1593000
CY2023 us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
121000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
1734000
us-gaap Restructuring Charges
RestructuringCharges
968000
us-gaap Payments For Restructuring
PaymentsForRestructuring
2472000
CY2024Q3 us-gaap Restructuring Reserve
RestructuringReserve
230000
CY2023Q3 glto Employees Retention Bonus Payable
EmployeesRetentionBonusPayable
1200000
glto Employees Retention Bonus Amount
EmployeesRetentionBonusAmount
200000
CY2023 glto Employees Retention Bonus Amount
EmployeesRetentionBonusAmount
400000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-3883000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8136000
us-gaap Net Income Loss
NetIncomeLoss
-14698000
us-gaap Net Income Loss
NetIncomeLoss
-31874000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1144978
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1144978
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1084191
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1084191
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1104849
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1104849
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1055679
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1055679
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.39
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.39
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.5
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.5
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-13.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-30.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-30.19
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 glto Rule10 B51 Arrmodifiedflag
Rule10B51Arrmodifiedflag
false
CY2024Q3 glto Nonrule10 B51 Arrmodifiedflag
Nonrule10B51Arrmodifiedflag
false

Files In Submission

Name View Source Status
0000950170-24-119809-index-headers.html Edgar Link pending
0000950170-24-119809-index.html Edgar Link pending
0000950170-24-119809.txt Edgar Link pending
0000950170-24-119809-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
glto-20240930.htm Edgar Link pending
glto-20240930.xsd Edgar Link pending
glto-ex31_1.htm Edgar Link pending
glto-ex31_2.htm Edgar Link pending
glto-ex32_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
glto-20240930_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable